EVIDENCE. COMPARISONS. CLEAR NEXT STEPS.FOR US CLINIC TEAMS PROCUREMENT RESEARCH
Readiness quiz

Are you ready to choose, renew or replace a GLP-1 supply arrangement?

Dose Diligence research deskSection 08 · Page 1 of 22Last updated 17 Nov 2026

Answer these 15 questions to identify whether your next step should be route clarification, supplier diligence, commercial comparison or controlled implementation. Score each answer from 0 to 3, for a maximum of 45 points. Five mandatory evidence gates override the total: strong pricing and operations cannot compensate for unresolved route eligibility, licensing, quality, clinical handling or health-data controls.

For: US weight-management and telehealth providers with 10–100 prescribers, particularly multi-state organisations with a supplier decision within six months.

Complete with: procurement or operations, finance, the medical director, and legal/compliance. Include security or technology leadership for data-sharing and integration questions.

Research review date: November 17, 2026.

This is a desk-developed procurement assessment, not a validated risk model, supplier accreditation, legal opinion or clinical assessment. Its points and thresholds are editorial decision rules—not regulatory standards or measured industry benchmarks. A high score does not establish that a preparation is lawful, a supplier is safe or treatment will be uninterrupted.

Sources cited on this page

    See the section’s source register for the research context.

    Section sources →